All Stories

  1. LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling
  2. Comparison of the Effects of Goat Dairy and Cow Dairy Based Breakfasts on Satiety, Appetite Hormones, and Metabolic Profile
  3. The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice
  4. RPL13A and EEF1A1 Are Suitable Reference Genes for qPCR during Adipocyte Differentiation of Vascular Stromal Cells from Patients with Different BMI and HOMA-IR
  5. Cannabinoids, eating behaviour, and energy homeostasis
  6. Leucine Supplementation Protects from Insulin Resistance by Regulating Adiposity Levels
  7. Leucine supplementation modulates fuel substrates utilization and glucose metabolism in previously obese mice
  8. Description of a Bivalent Cannabinoid Ligand with Hypophagic Properties
  9. Cocaine self-administration differentially modulates the expression of endogenous cannabinoid system-related proteins in the hippocampus of Lewis vs. Fischer 344 rats
  10. Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism
  11. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats
  12. The role of the endocannabinoid system in eating disorders
  13. Overexpression of Cannabinoid CB2 Receptor in the Brain Induces Hyperglycaemia and a Lean Phenotype in Adult Mice
  14. Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids
  15. Anti-obesity efficacy of LH-21, a cannabinoid CB1 receptor antagonist with poor brain penetration, in diet-induced obese rats
  16. Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animals
  17. Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity
  18. The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats
  19. Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors
  20. A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
  21. Distribution of diacylglycerol lipase alpha, an endocannabinoid synthesizing enzyme, in the rat forebrain
  22. The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction
  23. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
  24. Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions
  25. Estradiol Decreases Cortical Reactive Astrogliosis after Brain Injury by a Mechanism Involving Cannabinoid Receptors
  26. Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB 1 receptor blockade
  27. Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
  28. Maternal deprivation has sexually dimorphic long-term effects on hypothalamic cell-turnover, body weight and circulating hormone levels
  29. Synthesis of Fatty Acid Amides of Catechol Metabolites that Exhibit Antiobesity Properties
  30. Early maternal deprivation induces changes on the expression of 2-AG biosynthesis and degradation enzymes in neonatal rat hippocampus
  31. A sensitive method to analyse the effect of putative regulatory ligands on the release of glycoprotein from primary cultures of dispersed bovine subcommissural organ cells
  32. The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
  33. Effects of the endogenous PPAR-α agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice
  34. Endocannabinoid system in the adult rat circumventricular areas: An immunohistochemical study
  35. Opposite Clinical Phenotypes of Glucokinase Disease: Description of a Novel Activating Mutation and Contiguous Inactivating Mutations in Human Glucokinase (GCK) Gene
  36. Sex-dependent alterations in response to maternal deprivation in rats
  37. Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue
  38. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB1and CB2cannabinoid receptors of neonatal rats
  39. S1741 Expression of the Endocannabinoid System in Human Colonic Tissue: A Potencial Protective Role in Ulcerative Colitis
  40. EXPRESIÓN DEL SISTEMA ENDOCANNABINOIDE EN TEJIDO COLÓNICO HUMANO: UN POTENCIAL PAPEL PROTECTOR EN LA COLITIS ULCEROSA
  41. Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons
  42. The role of the pancreatic endocannabinoid system in glucose metabolism
  43. Rapid non-genomic regulation of Ca2+ signals and insulin secretion by PPAR  ligands in mouse pancreatic islets of Langerhans
  44. Critical Role of the Endocannabinoid System in the Regulation of Food Intake and Energy Metabolism, with Phylogenetic, Developmental, and Pathophysiological Implications
  45. Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei
  46. Central Versus Peripheral Antagonism of Cannabinoid CB1 Receptor in Obesity: Effects of LH-21, a Peripherally Acting Neutral Cannabinoid Receptor Antagonist, in Zucker Rats
  47. Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats
  48. Presence of functional cannabinoid receptors in human endocrine pancreas
  49. Plasma Visfatin Concentrations in Severely Obese Subjects Are Increased After Intestinal Bypass**
  50. Role of cannabinoid CB2 receptors in glucose homeostasis in rats
  51. PO6-167 CB1 CANNABINOID RECEPTORS REGULATE THE FATTY ACID METABOLISM IN MORBIDLY OBESE PERSONS
  52. Regulation of brain anandamide by acute administration of ethanol
  53. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies
  54. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection
  55. Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference
  56. Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell
  57. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats
  58. Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways
  59. Acute Δ-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion
  60. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats
  61. THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
  62. The subcommissural organ expresses D2, D3, D4, and D5 dopamine receptors
  63. Bovine subcommissural organ displays spontaneous and synchronous intracellular calcium oscillations
  64. Neurogenesis in explants from the walls of the lateral ventricle of adult bovine brain: role of endogenous IGF-1 as a survival factor
  65. Quantification of the secretory glycoproteins of the subcommissural organ by a sensitive sandwich ELISA with a polyclonal antibody and a set of monoclonal antibodies against the bovine Reissner's fiber